Rheumatology
SARS-CoV-2 and myocardial injury: Few answers, many questionsWhat is the mechanism? Is this a distinct population? What are the treatment options?
- Polymyalgia rheumatica: An updated review
Suspect it in older patients with bilateral shoulder and hip stiffness in the morning.
- A seaworthy nautical tale and a pictured rash
In history’s first randomized controlled trial, James Lind gave 2 sailors lemons and oranges, and they got better.
- Cytokines and the still-baffling clinical biology of COVID-19
The primary culprit is not certain. Is it all immune damage, or is the continued persistence of coronavirus playing a role?
- Cytokine storm and the prospects for immunotherapy with COVID-19
Despite gaping holes in our knowledge, treatment is evolving.
- Perioperative infection: Are we sure what to focus on?
Which immunosuppressive drugs pose the greater danger in the perioperative period: the newer biologics or corticosteroids?
- Is it safe to continue biologic agents during surgery in patients with inflammatory bowel disease?
Patients taking monoclonal antibodies can continue taking them, but small-molecule drugs should be withheld.
- Cutaneous adverse effects of biologic medications
These therapies have revolutionized medicine but come with many unique adverse effects.